Duration of Action of NPH Insulin
NPH insulin has a duration of action of approximately 12-16 hours, with peak effects occurring at 8-12 hours after injection. 1
Pharmacokinetic Profile of NPH Insulin
NPH (Neutral Protamine Hagedorn) insulin is an intermediate-acting insulin with the following characteristics:
- Onset of action: Begins to work within 1-2 hours after injection 2
- Peak effect: Occurs at approximately 8-12 hours after injection 1
- Duration of action: Typically lasts 12-16 hours, though studies have shown variability with ranges from 14-25 hours 2
This pharmacokinetic profile differs significantly from other insulin types:
- Short-acting (regular) insulin: Peaks at 2-3 hours, lasts 5-8 hours
- Long-acting insulins (e.g., glargine): Peakless profile lasting up to 24 hours 3
Clinical Implications of NPH Timing
The timing of NPH insulin administration is crucial due to its peak effect:
- Morning administration: When given in the morning, the peak effect occurs in the afternoon/evening, which may help cover daytime hyperglycemia but could be insufficient for overnight control 4
- Bedtime administration: When given at bedtime, the peak occurs overnight, which can better control fasting hyperglycemia but increases risk of nocturnal hypoglycemia 4, 5
Hypoglycemia Risk
The pronounced peak of NPH insulin at 8-12 hours creates a higher risk of hypoglycemia compared to newer long-acting insulin analogs. Studies have shown that patients using NPH insulin experience more nocturnal hypoglycemia (24% vs. 9.9%) compared to those using insulin glargine 5.
Mixing NPH with Other Insulins
When using NPH in combination with other insulins, important considerations include:
- NPH can be mixed with rapid-acting or short-acting insulins 6
- When mixed with rapid-acting insulin, the mixture should be injected within 15 minutes before a meal 6
- The pharmacokinetic profile of rapid-acting insulin is slightly affected when mixed with NPH, with a small decrease in absorption rate but not total bioavailability 6
- NPH should not be mixed with phosphate-buffered insulins or lente insulins due to potential precipitation and unpredictable action 6
Practical Dosing Considerations
For patients requiring NPH insulin:
- Initial dosing typically ranges from 0.1-0.2 units/kg/day 1
- Dose adjustments should be made in increments of 10-20% every 1-2 days based on blood glucose patterns 1
- When used for steroid-induced hyperglycemia, a ratio of approximately 0.4-0.5 units of NPH per mg of prednisone may be considered 1
- When tapering steroids, insulin must be reduced proportionally to prevent hypoglycemia 1
Common Pitfalls and Caveats
Overbasalization: Using excessive doses of NPH (>0.5 IU/kg) may lead to overbasalization, causing high bedtime-morning glucose differentials and increased hypoglycemia risk 6
Storage and Handling: NPH insulin should appear uniformly cloudy; any clumping, frosting, precipitation, or change in clarity may indicate loss of potency 1
Variability: NPH insulin has greater inter-individual variability in absorption and action compared to newer insulin analogs like glargine 3
Nocturnal Hypoglycemia: The peak action of NPH at 8-12 hours after injection makes nocturnal hypoglycemia a significant risk when administered at bedtime 5
NPH insulin remains a useful option for many patients, particularly when cost is a consideration, but its pronounced peak and shorter duration compared to newer analogs necessitates careful timing of administration and vigilant glucose monitoring.